Executive Control and ADHD Program
Overview
This program supports research of the causes, neurobiology, phenotypes, and efficacious treatments for Attention Deficit Hyperactivity Disorder and related disorders. It also supports basic research on related cognitive and biobehavioral processes such as executive functions, attentional processing, and sensory gating. Given that ADHD is by definition a disorder with onset in childhood and given that some important methods applicable to adults cannot be applied in child populations (e.g., receptor labeling with PET), this program will include grants on ADHD in adults.
Areas of Emphasis
- Investigations of the range of outcomes of individuals with ADHD and the factors that determine clinical course and prognosis.
- Establishing meaningful subtypes of the disorder (including comorbidities such as oppositional defiant disorder and others).
- Development of novel treatments, including pharmacological, psychosocial and cognitive treatments for the range of impairments seen in ADHD, including regulatory, motivational, and cognitive deficits that evolve across the lifespan.
- Understanding pathophysiology and mechanisms of treatment response.
- Identification of biomarkers.
Contact
Ann E. Wagner, Ph.D.
Program Chief
6001 Executive Boulevard, Room 7149, MSC 9633
301-443-3633, awagner@mail.nih.gov
